Cargando…
Proceedings of the 2013 CINP Summit: Innovative Partnerships to Accelerate CNS Drug Discovery for Improved Patient Care
Central nervous system (CNS) diseases and, in particular, mental health disorders, are becoming recognized as the health challenge of the 21(st) century. Currently, at least 10% of the global population is affected by a mental health disorder, a figure that is set to increase year on year. Meanwhile...
Autores principales: | Phillips, Anthony George, Hongaard-Andersen, Peter, Moscicki, Richard A., Sahakian, Barbara, Quirion, Rémi, Krishnan, K. Ranga Rama, Race, Tim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360252/ https://www.ncbi.nlm.nih.gov/pubmed/25542690 http://dx.doi.org/10.1093/ijnp/pyu100 |
Ejemplares similares
-
The rise of psychopharmacology and the story of the CINP
por: Marjot, David
Publicado: (2000) -
Strategies for Utilizing Neuroimaging Biomarkers in CNS Drug Discovery and Development: CINP/JSNP Working Group Report
por: Suhara, Tetsuya, et al.
Publicado: (2016) -
Biomarkers for Psychiatry: The Journey from Fantasy to Fact, a Report of the 2013 CINP Think Tank
por: Scarr, Elizabeth, et al.
Publicado: (2015) -
Proceedings of the Twelfth Annual UT-ORNL-KBRIN Bioinformatics Summit 2013
por: Rouchka, Eric C, et al.
Publicado: (2013) -
The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 3: The Clinical Guidelines
por: Fountoulakis, Konstantinos N., et al.
Publicado: (2016)